Talk:Vinflunine
Latest comment: 6 years ago by Rod57 in topic Seems to have been standard of care for 2nd line treatment of bladder cancer in europe
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Vinflunine.
|
Which countries have approved it
editWhich countries have approved it ? and when ? - Rod57 (talk) 11:27, 7 July 2016 (UTC)
Seems to have been standard of care for 2nd line treatment of bladder cancer in europe
editAccording to a quote in [1] "De Santis: The importance [of KEYNOTE-045 trial] starts with the history of treatment in the second-line setting for urothelial cancer. For many years, there was quite some uncertainty on how to treat those patients, because we did not have a global standard of care in the second-line setting. In the United States, people used taxanes and, in Europe, there was vinflunine." - so [when] was it approved [for this use] in europe ? - Rod57 (talk) 10:50, 22 November 2017 (UTC)